Literature DB >> 12939585

Left ventricular hypertrophy in rats with biliary cirrhosis.

Javier Inserte1, Antonia Perelló, Luis Agulló, Marisol Ruiz-Meana, Klaus-Dieter Schlüter, Noelia Escalona, Mariona Graupera, Jaume Bosch, David Garcia-Dorado.   

Abstract

Portal hypertension induces neuroendocrine activation and a hyperkinetic circulation state. This study investigated the consequences of portal hypertension on heart structure and function. Intrahepatic portal hypertension was induced in male Sprague-Dawley rats by chronic bile duct ligation (CBDL). Six weeks later, CBDL rats showed higher plasma angiotensin-II and endothelin-1 (P <.01), 56% reduction in peripheral resistance and 73% reduction in pulmonary resistance (P <.01), 87% increase in cardiac index and 30% increase in heart weight (P <.01), and increased myocardial nitric oxide (NO) synthesis. In CBDL rats, macroscopic analysis demonstrated a 30% (P <.01) increase in cross-sectional area of the left ventricular (LV) wall without changes in the LV cavity or in the right ventricle (RV). Histomorphometric analysis revealed increased cell width (12%, P <.01) of cardiomyocytes from the LV of CBDL rats, but no differences in myocardial collagen content. Myocytes isolated from the LV were wider (12%) and longer (8%) than right ventricular myocytes (P <.01) in CBDL rats but not in controls. CBDL rats showed an increased expression of ANF and CK-B genes (P <.01). Isolated perfused CBDL hearts showed pressure/end-diastolic pressure curves and response to isoproterenol identical to sham hearts, although generated wall tension was reduced because of the increased wall thickness. Coronary resistance was markedly reduced. This reduction was abolished by inhibition of NO synthesis with N-nitro-L-arginine. Expression of eNOS was increased in CBDL hearts. In conclusion, portal hypertension associated to biliary cirrhosis induces marked LV hypertrophy and increased myocardial NO synthesis without detectable fibrosis or functional impairment. This observation could be relevant to patients with cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12939585     DOI: 10.1053/jhep.2003.50369

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  6 in total

1.  The impact of left ventricular hypertrophy on survival in candidates for liver transplantation.

Authors:  Sachin Batra; Victor I Machicao; John S Bynon; Shivang Mehta; Rajasekhar Tanikella; Michael J Krowka; Steven Zacks; James Trotter; Kari E Roberts; Robert S Brown; Steven M Kawut; Michael B Fallon
Journal:  Liver Transpl       Date:  2014-06       Impact factor: 5.799

2.  Cardiac structural and functional alterations in infants and children with biliary atresia, listed for liver transplantation.

Authors:  Moreshwar S Desai; Shabier Zainuer; Curtis Kennedy; Debra Kearney; John Goss; Saul J Karpen
Journal:  Gastroenterology       Date:  2011-07-14       Impact factor: 22.682

3.  Hypertrophic cardiomyopathy and dysregulation of cardiac energetics in a mouse model of biliary fibrosis.

Authors:  Moreshwar S Desai; Zainuer Shabier; Michael Taylor; Fong Lam; Sundararajah Thevananther; Astrid Kosters; Saul J Karpen
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

4.  Contribution of mammalian target of rapamycin in the pathophysiology of cirrhotic cardiomyopathy.

Authors:  Seyed Soheil Saeedi Saravi; Mahmoud Ghazi-Khansari; Shahram Ejtemaei Mehr; Maliheh Nobakht; Seyyedeh Elaheh Mousavi; Ahmad Reza Dehpour
Journal:  World J Gastroenterol       Date:  2016-05-21       Impact factor: 5.742

5.  Cardiac health in patients with hepatitis B virus-related cirrhosis.

Authors:  Wei Yuan; Hong-Zhou Lu; Xue Mei; Yu-Yi Zhang; Zheng-Guo Zhang; Ying Zou; Jie-Fei Wang; Zhi-Ping Qian; Hong-Ying Guo
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

6.  Haemodynamic changes in cirrhosis following terlipressin and induction of sepsis-a preclinical study using caval subtraction phase-contrast and cardiac MRI.

Authors:  Manil D Chouhan; Stuart A Taylor; Alan Bainbridge; Simon Walker-Samuel; Nathan Davies; Steve Halligan; Mark F Lythgoe; Rajeshwar P Mookerjee
Journal:  Eur Radiol       Date:  2020-10-12       Impact factor: 5.315

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.